Anti-FCRL5 Chimeric Antigen Receptor (CAR) Targeting Multiple Myeloma

by | May 14, 2025 | DiPersio, John, Ghobadi, Armin, O'Neal, Julie, Ritchey, Julie

— Published Date: 5/13/2025

Value Proposition: An innovative therapy leveraging unique chimeric antigen receptors (CAR) to specifically target Fc receptor-like 5 (FCRL5), enabling the precise elimination of FCRL5-expressing cells to treat multiple myeloma and other cancers.

Technology Description

…